ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
28 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
630
|
267K
|
28
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Patient Response in Pancreatic Cancer Trial
|
|
ma420
|
30 |
12K |
9 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
30
|
12K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
ma420
|
31 |
10K |
8 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
31
|
10K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
245K |
13 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
663
|
245K
|
13
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
ma420
|
17 |
5.1K |
3 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
17
|
5.1K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
1.2K |
455K |
1 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.2K
|
455K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
1.2K |
455K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.2K
|
455K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
630
|
267K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
1.2K |
455K |
6 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.2K
|
455K
|
6
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
287 |
159K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
287
|
159K
|
8
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
287 |
159K |
13 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
287
|
159K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
1.2K |
455K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.2K
|
455K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
12K |
4.2M |
2 |
05/08/24 |
05/08/24 |
General
|
12K
|
4.2M
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
245K |
10 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
663
|
245K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Biggin
|
|
ma420
|
1 |
1.0K |
9 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1
|
1.0K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
ma420
|
36 |
8.4K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
36
|
8.4K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
ma420
|
36 |
8.4K |
4 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
36
|
8.4K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
ma420
|
117 |
32K |
6 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
117
|
32K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
ma420
|
81 |
24K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
81
|
24K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
245K |
5 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
663
|
245K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
245K |
24 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
663
|
245K
|
24
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
630
|
267K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
13 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
630
|
267K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
16 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
630
|
267K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
3 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
630
|
267K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
1 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
630
|
267K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
14 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
630
|
267K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
630
|
267K
|
9
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Placement & ANREO to raise up to 13.6m
|
|
ma420
|
11 |
4.6K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
11
|
4.6K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Taylor
|
|
ma420
|
6 |
2.0K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
2.0K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
12 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
630
|
267K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
8 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
630
|
267K
|
8
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Placement & ANREO to raise up to 13.6m
|
|
ma420
|
11 |
4.6K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
11
|
4.6K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
8 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
132
|
34K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
21 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
630
|
267K
|
21
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Application for quotation of securities - CU6
|
|
ma420
|
5 |
1.9K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5
|
1.9K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
132
|
34K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
12 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
630
|
267K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
ma420
|
81 |
24K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
21 |
6.9K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
21
|
6.9K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
21 |
6.9K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
21
|
6.9K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
ma420
|
81 |
24K |
29 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
29
|
|
ASX - By Stock
|
FND |
Re:
Ann: FND FY25 Guidance & Market Update Presentation
|
|
ma420
|
32 |
15K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
32
|
15K
|
0
|
|
ASX - By Stock
|
FND |
Re:
Ann: FND FY25 Guidance & Market Update Presentation
|
|
ma420
|
32 |
15K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
32
|
15K
|
1
|
|
ASX - By Stock
|
FND |
Re:
Ann: FND FY25 Guidance & Market Update Presentation
|
|
ma420
|
32 |
15K |
9 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
32
|
15K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
245K |
26 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
663
|
245K
|
26
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
21 |
6.9K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
6.9K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
18 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
630
|
267K
|
18
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
ma420
|
31 |
10K |
4 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
31
|
10K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
ma420
|
483 |
184K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
483
|
184K
|
6
|
|